< Arab Finance - News - Investment entity aims to acquire 5% stake in Rameda
Count Down to relaunch



Investment entity aims to acquire 5% stake in Rameda

Investment entity aims to acquire 5% stake in Rameda

ArabFinance: One of the shareholders of Tenth of Ramadan for Pharmaceuticals Industries and Diagnostic Reagents (Rameda) (RMDA) is considering selling not over 5% of the company’s shares to an investment entity, according to a statement filed to the Egyptian Exchange (EGX).

This will be discussed during the ordinary general meeting (OGM) set to be held on November 25th, 2021.

The identities of the shareholder and the investment entity have not been revealed yet.

Rameda is an Egypt-based pharmaceutical company that manufactures both human and veterinary pharmaceuticals.

It operates three fully independent factories at its plant, including 20 production lines capable of producing a wide range of general medicinal forms, namely eye drops, solid dosage forms, syrups, blow-fill-seal, and lyophilized vials, among others.

 

#Related keywords

'

Recommended Stocks

13 Jun 2022
Delta Sugar SUGR
Close
14.06
Change
-00.92
Hold

All rights reserved to Arab Finance 2020 ©

Back to top